Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

173 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
13C-erythromycin breath test as a noninvasive measure of CYP3A activity in newborn infants: a pilot study.
de Wildt SN, Berns MJ, van den Anker JN. de Wildt SN, et al. Ther Drug Monit. 2007 Apr;29(2):225-30. doi: 10.1097/FTD.0b013e31803d156d. Ther Drug Monit. 2007. PMID: 17417078
Glucuronidation in humans. Pharmacogenetic and developmental aspects.
de Wildt SN, Kearns GL, Leeder JS, van den Anker JN. de Wildt SN, et al. Clin Pharmacokinet. 1999 Jun;36(6):439-52. doi: 10.2165/00003088-199936060-00005. Clin Pharmacokinet. 1999. PMID: 10427468 Review.
Cytochrome P450 3A: ontogeny and drug disposition.
de Wildt SN, Kearns GL, Leeder JS, van den Anker JN. de Wildt SN, et al. Clin Pharmacokinet. 1999 Dec;37(6):485-505. doi: 10.2165/00003088-199937060-00004. Clin Pharmacokinet. 1999. PMID: 10628899 Review.
Use of saliva in therapeutic drug monitoring of caffeine in preterm infants.
de Wildt SN, Kerkvliet KT, Wezenberg MG, Ottink S, Hop WC, Vulto AG, van Den Anker JN. de Wildt SN, et al. Ther Drug Monit. 2001 Jun;23(3):250-4. doi: 10.1097/00007691-200106000-00011. Ther Drug Monit. 2001. PMID: 11360033
Pharmacokinetics and metabolism of intravenous midazolam in preterm infants.
de Wildt SN, Kearns GL, Hop WC, Murry DJ, Abdel-Rahman SM, van den Anker JN. de Wildt SN, et al. Clin Pharmacol Ther. 2001 Dec;70(6):525-31. doi: 10.1067/mcp.2001.120683. Clin Pharmacol Ther. 2001. PMID: 11753268 Clinical Trial.
Pharmacokinetics and metabolism of oral midazolam in preterm infants.
de Wildt SN, Kearns GL, Hop WC, Murry DJ, Abdel-Rahman SM, van den Anker JN. de Wildt SN, et al. Br J Clin Pharmacol. 2002 Apr;53(4):390-2. doi: 10.1046/j.1365-2125.2002.01223.x. Br J Clin Pharmacol. 2002. PMID: 11966671 Free PMC article.
Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients.
de Wildt SN, de Hoog M, Vinks AA, van der Giesen E, van den Anker JN. de Wildt SN, et al. Among authors: de hoog m. Crit Care Med. 2003 Jul;31(7):1952-8. doi: 10.1097/01.ccm.0000084806.15352.da. Crit Care Med. 2003. PMID: 12847388
Pharmacodynamics of midazolam in pediatric intensive care patients.
de Wildt SN, de Hoog M, Vinks AA, Joosten KF, van Dijk M, van den Anker JN. de Wildt SN, et al. Among authors: de hoog m. Ther Drug Monit. 2005 Feb;27(1):98-102. doi: 10.1097/00007691-200502000-00018. Ther Drug Monit. 2005. PMID: 15665754 Clinical Trial.
Challenges for drug studies in children: CYP3A phenotyping as example.
de Wildt SN, Ito S, Koren G. de Wildt SN, et al. Drug Discov Today. 2009 Jan;14(1-2):6-15. doi: 10.1016/j.drudis.2008.07.007. Epub 2008 Sep 7. Drug Discov Today. 2009. PMID: 18721895 Review.
Tailor-made drug treatment for children: creation of an infrastructure for data-sharing and population PK-PD modeling.
Ince I, de Wildt SN, Tibboel D, Danhof M, Knibbe CA. Ince I, et al. Among authors: de wildt sn. Drug Discov Today. 2009 Mar;14(5-6):316-20. doi: 10.1016/j.drudis.2008.11.004. Epub 2008 Dec 26. Drug Discov Today. 2009. PMID: 19059496 Review.
173 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback